title: Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Bloch
authors.forename: Jan N
authors.initials: JN
authors.lastname: Basile
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D044383:Black People / Q000208:ethnology*; D001794:Blood Pressure / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000208:ethnology* / Q000503:physiopathology; D008019:Life Style; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D049993:Sodium Chloride Symporter Inhibitors